Alcon’s PATANASE nasal spray approved by FDA for treatment of nasal allergic reactions Alcon, Inc www.DapoxetineForSale.com . Offers announced that the U.S. Food and Medication Administration has authorized PATANASE nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. PATANASE nasal spray, an extension to Alcon’s market-leading ocular allergy products, will be available in May of this year. ‘We look forward to providing doctors the chance to prescribe PATANASE to their patients who want and need a fast-acting nasal spray that quickly relieves symptoms,’ said Kevin Buehler, Alcon’s senior vice president, global markets and chief marketing officer.
‘ Staffed by experienced, registered nurses, Nurse24 offers a cost-effective solution for connecting anyone an company or health plan people who has a question or medical problem with around-the-clock health advice, guidance and educational support. Health information managers help individuals navigate through concerns and queries about symptoms, appropriate treatment options, co-morbid conditions and extra risk factors, along with refer them to relevant health care services. With an 87 percent participant satisfaction rating, Nurse24 helps individuals avoid unnecessary doctor and emergency room visits and serves as an ‘early warning system’ for emerging health issues before they become expensive, acute, medical events..